Travere Therapeutics competitorsClear all

Travere Therapeutics's top competitors include Genexine, Bath ASU and Kamada Pharmaceuticals.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Travere Therapeutics
Travere Therapeutics
Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.
Genexine
Genexine
Genexine is a biotechnology company focused on the development and commercialization of immunotherapeutics and long-acting biologics.
Bath ASU
Bath ASU
Bath ASU (also known as Qualasept) is a pharmaceutical specials manufacturer.
Kamada Pharmaceuticals
Kamada Pharmaceuticals
Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications.
Founding Date
Founding Date
2011
Founding Date
1999
Founding Date
2006
Founding Date
1990
Type
Type
Public
Type
Public
Type
Private
Type
Public
Tags
Locations
Locations
San Diego, US HQ
Dublin, IE
Locations
Seongnam-si, KR HQ
New York, US
Locations
Corsham, GB HQ
Locations
Rehovot, IL HQ
Beit Kama, IL
Employees
Employees
2398% increase
Employees
102
Employees
1046% increase
Employees
408
Valuation ($)
Valuation ($)
1.5 b
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
209.5 m
Twitter followers
Twitter followers
15
Twitter followers
N/A
Twitter followers
246
Twitter followers
N/A
Alexa Website Rank
Alexa Website Rank
404012
Alexa Website Rank
636431
Alexa Website Rank
N/A
Alexa Website Rank
859663
Employee Rating
Employee Rating
4.4
Employee Rating
5
Employee Rating
2.5
Employee Rating
3.7

Financial

Revenue (est.)
Revenue (est.)
$198.3m (FY, 2020)
Revenue (est.)
₩36.8b (FY, 2021)
Revenue (est.)
N/A
Revenue (est.)
$103.6m (FY, 2021)
Cost of goods
Cost of goods
$6.1m (FY, 2020)
Cost of goods
(₩2.1b) (FY, 2021)
Cost of goods
N/A
Cost of goods
($52.8m) (FY, 2021)
Gross profit
Gross profit
$192.2m (FY, 2020)
Gross profit
₩36.6b (FY, 2021)
Gross profit
N/A
Gross profit
$50.9m (FY, 2021)
Net income
Net income
($169.4m) (FY, 2020)
Net income
(₩48.6b) (FY, 2021)
Net income
N/A
Net income
($2.2m) (FY, 2021)

Funding

Total funding raised
Total funding raised
$ 25m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 90m
For sources of this data, please see the company profile

View company profiles

Genexine
HQ
Seongnam-si, KR
Employees
102

Genexine is a biotechnology company focused on the development and commercialization of immunotherapeutics and long-acting biologics.

View company
Bath ASU
HQ
Corsham, GB
Employees
104↑ 6% increase

Bath ASU (also known as Qualasept) is a pharmaceutical specials manufacturer.

View company
Kamada Pharmaceuticals
HQ
Rehovot, IL
Employees
408

Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications.

View company